Identity
- Security key
- 12290
- Ticker
- BBNX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2025-01-30
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- BBNX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $779,671,293.04
- Shares outstanding (class)
- 44,989,688
- Shares outstanding (weighted)
- 44,989,688
- SIC
- 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Employees
- 423
- Location
- IRVINE, CA
- Homepage
- https://www.betabionics.com
- Description
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.